Q03111 (ENL_HUMAN) Homo sapiens (Human)
Protein ENL UniProtKBInterProSTRINGInteractive Modelling
559 aa; Sequence (Fasta)
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of ENL T4 mutant YEATS domain in complex with histone H3 acetylation at K27 |
Heteromer P68431; | 100 | ||||
| ENL YEATS in complex with histone H3 acetylation at K27 |
Heteromer P68431; | 100 | 4×SO4; | |||
| Crystal structure of ENL T1(H116P) mutant YEATS domain in complex with histone H3 acetylation at K27 |
Heteromer P68431; | 100 | ||||
| Crystal structure of ENL T1 mutant YEATS domain in complex with histone H3 acetylation at K27 |
Heteromer P68431; | 100 | ||||
| Crystal structure of ENL YEATS domain T2 mutant in complex with histone H3 acetylation at K27 |
Heteromer P68431; | 100 | 1×CIT; | |||
| Crystal structure of ENL YEATS domain T1 mutant in complex with histone H3 acetylation at K27 | monomer | 100 | 2×EDO; 2×IOD; | |||
| Crystal structure of MLLT1 (ENL) YEATS domain in complexed with compound 94 | monomer | 100 | 1×SO4; 8×EDO; 1×GQ8; | |||
| Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 1 | monomer | 100 | 1×M7W; 10×EDO; | |||
| Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 2 | monomer | 100 | 7×EDO; 1×M7T; | |||
| Crystal structure of MLLT1 (ENL) YEATS domain in complexed with SGC-iMLLT (compound 92) | monomer | 100 | 2×SO4; 7×EDO; 1×GQ5; | |||
| Crystal structure of ENL (MLLT1) in complex with compound 19 | monomer | 100 | 4×EDO; 1×GKQ; | |||
| Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 4 | monomer | 100 | 1×M8K; 7×EDO; | |||
| Crystal structure of ENL (MLLT1) in complex with compound 20 | monomer | 100 | 8×EDO; 1×GKT; | |||
| Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 3 | monomer | 100 | 10×EDO; 1×M7N; | |||
| Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 6 | monomer | 100 | 1×M82; 5×EDO; | |||
| Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 5 | monomer | 100 | 1×M7Z; 7×EDO; | |||
| Crystal structure of ENL (MLLT1) in complex with compound 12 | monomer | 100 | 3×EDO; 1×SO4; 1×GKN; | |||
| MLLT1 in complex with compound 10a | monomer | 100 | 2×EDO; 1×DMS; 1×ZJF; 1×SO4; | |||
| Crystal structure of MLLT1 YEATS domain T3 mutant in complex with benzimidazole-amide based compoun… | monomer | 99.07 | 1×GKT; 5×EDO; | |||
| Crystal structure of ENL (MLLT1) in complex with acetyllysine | monomer | 100 | 2×EDO; 1×ALY; | |||
| Crystal structure of ENL (MLLT1), apo form | monomer | 100 | 5×EDO; | |||
| Crystal structure of MLLT1 YEATS domain T1 mutant in complex with benzimidazole-amide based compoun… | monomer | 100 | 1×GKT; 1×IOD; 11×EDO; | |||
| Crystal structure of apo ENL YEATS domain T3 mutant | monomer | 99.06 | ||||
| Crystal structure of ENL YEATS domain T3 mutant in complex with histone H3 acetylation at K27 | monomer | 99.06 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7eid.2.A | monomer | 0.76 | 81.88 | |||
| 8tlw.1.A | monomer | 0.67 | 68.60 | |||
| 2lm0.1.A | monomer | 0.57 | 65.59 | |||